Psychemedics Reports Q2 EPS Of $(0.14), Down From $(0.13) Prior Year; Revenue Decrease 15% To $4.7M From $5.5M Last Year
Portfolio Pulse from Benzinga Newsdesk
Psychemedics reported a Q2 EPS of $(0.14), a slight decline from $(0.13) in the prior year. Revenue also decreased by 15% to $4.7M from $5.5M last year.
August 13, 2024 | 8:56 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Psychemedics reported a Q2 EPS of $(0.14), a slight decline from $(0.13) in the prior year. Revenue also decreased by 15% to $4.7M from $5.5M last year.
The decline in both EPS and revenue indicates a negative performance trend, which is likely to impact the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100